Bray Patrick-Lake, MFS
Director of Stakeholder Engagement and Research Together Program Lead at Duke Clinical Research Institute
As Director of Stakeholder Engagement and Research Together Program Lead, Bray Patrick-Lake supports efforts to actively engage patients, health advocacy organizations, and other stakeholders in Duke Clinical Research Institute’s local and national research programs. She has led extensive efforts through the Clinical Trials Transformation Initiative to incorporate patient voice into clinical trial design, conduct, oversight, and regulatory frameworks, as well as improvement of the clinical trial enterprise.
She currently serves as the DCRI Coordinating Center’s engagement lead for the Project Baseline study and NIH’s Environmental Influences on Child Health Outcomes program. In 2015 – 2016, she co-chaired the Advisory Committee to the NIH Director’s Working Group responsible for authoring the vision and roadmap to launch the Precision Medicine Initiative Cohort Program. She served as the Interim Director of Engagement for several months after program launch. She currently serves on the National Academies of Science, Engineering, and Medicine Board on Health Sciences Policy, the All of Us National Advisory Panel, and leads engagement work at Duke’s Coordinating Center for NIH’s Environmental Influences on Child Health Outcomes (ECHO) program.
In 2010, Ms. Patrick-Lake founded the Patent Foramen Ovale (PFO) Research Foundation in response to the lack of definitive scientific information regarding the condition of PFO after being a patient in an aborted device clinical trial. Ms. Patrick-Lake has served as a patient representative at the FDA on a variety of advisory committees and panels, in workgroups for EMA, IMI, NIH, and NAM/IOM, and as a patient stakeholder or co-investigator for AHRQ and PCORI research projects.
She was a member of the PCORnet Coordinating Center’s Executive Leadership Committee where she developed patient engagement strategies and has served on the MDEpiNet’s National Medical Device Registry Task Force, the Medical Device Innovation Consortium’s Patient-centered Benefit-Risk Steering Committee, American College of Cardiology (ACC) Foundation’s Patient-centered Care Shared Decision Making and Patient-generated Health Data working groups, and the ACC Transcatheter Valve Therapy Registry Stakeholder Advisory Committee.